.png "cropped-MPS-logo-transparent (1)"){kind=logo}
The MPS World Summit is a leading international conference focused on microphysiological systems (MPS) and organ-on-chip technologies, bringing together scientists from industry, academia, and regulatory agencies to advance human-relevant models for biomedical research and drug development and highlights cutting-edge innovations in NAMs, translational ADME/DMPK, disease modeling, and toxicity testing.
LifeNet Health LifeSciences will be exhibiting at MPS World Summit 2026, where we will showcase our portfolio of human-relevant solutions designed to advance research across ADME, DMPK, and toxicity assessment. Our solutions include an integrated multi-organ microphysiological (MPS) platform, advanced in vitro systems, and high-quality prospective human biospecimens, to generate more predictive, biologically relevant data for drug development and safety assessment.
High Quality Solutions that Better Represent Human Biology
Cells & Cell Models
- Primary Human Cells
- TruVivo® 2D+ Hepatic System
- 3D Thyroid Microtissues
Prospective Biospecimens
- Brain, Skin, Gut, and More
- Healthy and Diseased
- Prospective Samples
Innovative NAMs Advancing Translational Science
.png?width=225&height=225&name=MPS%20diagram%20(1).png "MPS diagram (1)")
Integrated Multi-Organ MPS Platform
Our integrated multi-organ MPS platform provides flexible, human-relevant evaluation of pharmacokinetics and toxicity with greater simplicity and affordability than traditional organ-on-chip systems. Isolated tissues are linked via simulated vascular flow in configurable 2-, 3-, or 4-organ designs, such as intestine–liver–kidney or intestine–liver–thyroid, enabling simultaneous assessment of metabolism, clearance, and organ-specific toxicity. The system supports key PK parameters, PBPK modeling, improved IVIVE, and can be deployed in GLP study designs.
TruVivo® 2D+ Hepatic System
TruVivo is an advanced 2D+ hepatic platform that bridges the gap between traditional cell culture and complex 3D models. Built to fit seamlessly into existing hepatocyte workflows, TruVivo combines extended functionality with ease of use and experimental flexibility. Its 3D-like architectural integrity maintains stable metabolic activity over extended timeframes, enabling critical low-clearance and long-term induction studies. Available via ready-to-use-in-house kits or expert services, TruVivo delivers human-relevant data that scales to your laboratory’s unique demands.
Poster Presentation
Toxicokinetic Assessment of Oral Drug Formulations Using a Human-Based Microphysiological System
Date & Time: Wednesday, May 27 | 9:30 – 11 AM
Poster Session: 1
Board No. 186
This study utilizes a three-organ human-based MPS model—linking intestine, liver (TruVivo), and kidney via simulated vascular flow—to assess an API delivered through a self-nano-emulsifying drug delivery system (SNEDDS).
Presenter: Alec Salminen, PhD
Manager, In Vitro Assay Services
By integrating multi-organ MPS technology, human hepatic modeling, and prospectively sourced biospecimens, LifeNet Health LifeSciences enables a continuum of biologically relevant tools that support more predictive decision-making in drug development.
Our solutions are designed to help researchers move beyond reductionist systems toward connected, human-relevant models that better reflect clinical biology.